Suchergebnisse - Megan Garrity-Park
- Treffer 1 - 8 von 8
-
1
Myeloperoxidase Immunohistochemistry as a Measure of Disease Activity in Ulcerative Colitis: Association With Ulcerative Colitis-Colorectal Cancer, Tumor Necrosis Factor Polymorphi... von Megan Garrity-Park, Edward V. Loftus, William J. Sandborn, Thomas C. Smyrk
Veröffentlicht 2011Artigo -
2
Upregulation of DNA Methyltransferase–Mediated Gene Silencing, Anchorage-Independent Growth, and Migration of Colon Cancer Cells by Interleukin-6 von Eílis Foran, Megan Garrity-Park, Coralie Mureau, John Newell, Thomas C. Smyrk, Paul J. Limburg, Laurence J. Egan
Veröffentlicht 2010Artigo -
3
SULF1 Inhibits Tumor Growth and Potentiates the Effects of Histone Deacetylase Inhibitors in Hepatocellular Carcinoma von Jinping Lai, Chunrong Yu, Catherine D. Moser, Ileana Aderca, Tao Han, Thomas D. Garvey, Linda M. Murphy, Megan Garrity-Park, Viji Shridhar, Alex A. Adjei, Lewis R. Roberts
Veröffentlicht 2006Artigo -
4
Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation Injury von ES Baskin-Bey, Kenneth Washburn, Sandy Feng, Tilman Oltersdorf, Д. А. Шапиро, MiRa Huyghe, Lawrence J. Burgart, Megan Garrity-Park, FGI Van Vilsteren, L. P. Oliver, CB Rosen, GJ Gores
Veröffentlicht 2006Artigo -
5
Apoptotic cell death of human interstitial cells of Cajal von Simon J. Gibbons, Roberto De Giorgio, Massimo Pellegrini, Megan Garrity-Park, Steven Miller, P. F. Schmalz, Tonia M. Young‐Fadok, David W. Larson, Eric J. Dozois, Michael Camilleri, Vincenzo Stanghellini, Joseph H. Szurszewski, Gianrico Farrugia
Veröffentlicht 2008Artigo -
6
Stool <scp>DNA</scp> testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease von John B. Kisiel, Tracy C. Yab, Fareeda Taher Nazer Hussain, William R. Taylor, Megan Garrity-Park, William J. Sandborn, Edward V. Loftus, B. G. Wolff, Thomas C. Smyrk, Steven H. Itzkowitz, David T. Rubin, Hongzhi Zou, Douglas W. Mahoney, David A. Ahlquist
Veröffentlicht 2013Artigo -
7
The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation von Jin-Ping Lai, Abdul M. Oseini, Catherine D. Moser, Chunrong Yu, Sherine F. Elsawa, Chunling Hu, Ikuo Nakamura, Tao Han, Ileana Aderca, Hajime Isomoto, Megan Garrity-Park, Abdirashid M. Shire, Jia Li, Schuyler O. Sanderson, Alex A. Adjei, Martín E. Fernández-Zapico, Lewis R. Roberts
Veröffentlicht 2010Artigo -
8
Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma von Jinping Lai, Dalbir S. Sandhu, Chunrong Yu, Tao Han, Catherine D. Moser, Kenard K. Jackson, Rubén Bonilla Guerrero, Ileana Aderca, Hajime Isomoto, Megan Garrity-Park, Hongzhi Zou, Abdirashid M. Shire, David M. Nagorney, Schuyler O. Sanderson, Alex A. Adjei, Ju–Seog Lee, Snorri S. Thorgeirsson, Lewis R. Roberts
Veröffentlicht 2008Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Biology
Medicine
Biochemistry
Cancer
Cancer research
Internal medicine
Cell biology
Colorectal cancer
Gastroenterology
Genetics
Immunohistochemistry
Immunology
Pathology
Apoptosis
Carcinogenesis
Cell culture
Chemistry
Disease
Gene
Gene knockdown
Glypican 3
Hepatocellular carcinoma
Inflammatory bowel disease
Signal transduction
Small hairpin RNA
TUNEL assay
Acetylation
Alternative medicine
Andrology
Cell growth